Literature DB >> 17531688

Sequential Intacs and Verisyse phakic intraocular lens for refractive improvement in keratoconic eyes.

Tamer M El-Raggal1, Adel A Abdel Fattah.   

Abstract

PURPOSE: To evaluate the safety, efficacy, and stability of sequential Intacs (Addition Technology, Inc.) insertion and Verisyse phakic intraocular lens (pIOL) (AMO) implantation in selected cases of keratoconus.
SETTING: Magrabi Eye Hospital, Cairo, Egypt.
METHODS: Prospective data were collected from 8 eyes of 6 keratoconus patients with contact lens intolerance, clear corneas, a maximum K-value less than 60.0 diopters (D), and minimum corneal thickness greater than 400 mum. Two 0.45 mm Intacs were inserted through a 1.8 mm radial incision created at 70% of the corneal depth opposite the cone apex. The 2 rings were pushed to meet and embrace the cone apex. Refraction 6 months after Intacs insertion showed residual myopia greater than 6.0 D and residual astigmatism not more than 2.0 D. Thus, a phakic Verisyse IOL was implanted horizontally in the anterior chamber through a 6.5 mm superior clear corneal incision, which was closed with 3, 10-0 nylon sutures after a peripheral iridectomy was created. The uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), refraction, and topographic profiles were taken 1 week and 1, 3, 6, 9, 12, 18, and 24 months after the second surgery.
RESULTS: All eyes achieved UCVA of 20/40 or better. The final spherical error ranged from -1.75 to +1.00 D and the cylindrical error, from 1.25 to 2.50 D. No eye lost lines of preoperative BCVA. These results were relatively stable throughout the follow-up period.
CONCLUSIONS: Sequential Intacs and a Verisyse pIOL implantation was safe, stable, and effective in selected cases of keratoconus. It is a reversible surgery that is less invasive than penetrating keratoplasty (PKP). It can avoid or postpone the need for PKP, although it is not an alternative.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17531688     DOI: 10.1016/j.jcrs.2007.02.024

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  9 in total

Review 1.  INTACS for keratoconus.

Authors:  Yaron S Rabinowitz
Journal:  Int Ophthalmol Clin       Date:  2006

Review 2.  New clinical pathways for keratoconus.

Authors:  D M Gore; A J Shortt; B D Allan
Journal:  Eye (Lond)       Date:  2012-12-21       Impact factor: 3.775

3.  Clinical outcomes of posterior chamber toric phakic intraocular lens implantation for the correction of high myopic astigmatism in eyes with keratoconus: 6-month follow-up.

Authors:  Kazutaka Kamiya; Kimiya Shimizu; Hidenaga Kobashi; Mari Komatsu; Akio Nakamura; Tomoaki Nakamura; Kazuo Ichikawa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-10-16       Impact factor: 3.117

Review 4.  INTACS for keratoconus and ectasia after LASIK.

Authors:  Yaron S Rabinowitz
Journal:  Int Ophthalmol Clin       Date:  2013

5.  Keratoconus: overview and update on treatment.

Authors:  Ladan Espandar; Jay Meyer
Journal:  Middle East Afr J Ophthalmol       Date:  2010-01

6.  Femtosecond laser-assisted implantation of complete versus incomplete rings for keratoconus treatment.

Authors:  Mohamed Hosny; Esraa El-Mayah; Mohamed Karim Sidky; Mohamed Anis
Journal:  Clin Ophthalmol       Date:  2015-01-20

Review 7.  Surgical Options for the Refractive Correction of Keratoconus: Myth or Reality.

Authors:  L Fernández-Vega-Cueto; V Romano; R Zaldivar; C H Gordillo; F Aiello; D Madrid-Costa; J F Alfonso
Journal:  J Ophthalmol       Date:  2017-12-18       Impact factor: 1.909

8.  Complete corneal ring (MyoRing) implantation versus MyoRing implantation combined with corneal collagen crosslinking for keratoconus: 3-year follow-up.

Authors:  Guzel Bikbova; Gyulli Kazakbaeva; Mukharram Bikbov; Emin Usubov
Journal:  Int Ophthalmol       Date:  2017-06-15       Impact factor: 2.031

Review 9.  Efficacy of Different Procedures of Intra-Corneal Ring Segment Implantation in Keratoconus: a Systematic Review and Meta-Analysis.

Authors:  Cédric Benoist d'Azy; Bruno Pereira; Frédéric Chiambaretta; Frédéric Dutheil
Journal:  Transl Vis Sci Technol       Date:  2019-06-11       Impact factor: 3.283

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.